| Late-stage functionalization for improving drug-like molecular properties NJ Castellino, AP Montgomery, JJ Danon, M Kassiou Chemical reviews 123 (13), 8127-8153, 2023 | 36 | 2023 |
| Computational glycobiology: Mechanistic studies of carbohydrate-active enzymes and implication for inhibitor design AP Montgomery, K Xiao, X Wang, D Skropeta, H Yu Advances in protein chemistry and structural biology 109, 25-76, 2017 | 31 | 2017 |
| Recent scaffold hopping applications in central nervous system drug discovery TB Callis, TR Garrett, AP Montgomery, JJ Danon, M Kassiou Journal of Medicinal Chemistry 65 (20), 13483-13504, 2022 | 23 | 2022 |
| Computational characterisation of the interactions between human ST6Gal I and transition‐state analogue inhibitors: insights for inhibitor design A Montgomery, R Szabo, D Skropeta, H Yu Journal of Molecular Recognition 29 (5), 210-222, 2016 | 22 | 2016 |
| Transition state-based ST6Gal I inhibitors: Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation AP Montgomery, D Skropeta, H Yu Scientific Reports 7 (1), 14428, 2017 | 19 | 2017 |
| DYRK1A negatively regulates CDK5-SOX2 pathway and self-renewal of glioblastoma stem cells B Chen, D McCuaig-Walton, S Tan, AP Montgomery, BW Day, M Kassiou, ... International journal of molecular sciences 22 (8), 4011, 2021 | 16 | 2021 |
| Design, synthesis and evaluation of carbamate-linked uridyl-based inhibitors of human ST6Gal I AP Montgomery, C Dobie, R Szabo, L Hallam, M Ranson, H Yu, ... Bioorganic & Medicinal Chemistry 28 (14), 115561, 2020 | 16 | 2020 |
| Computer‐aided design of human sialyltransferase inhibitors of hST8Sia III C Dobie, AP Montgomery, R Szabo, D Skropeta, H Yu Journal of Molecular Recognition 31 (2), e2684, 2018 | 9 | 2018 |
| An update on late-stage functionalization in today’s drug discovery AP Montgomery, JM Joyce, JJ Danon, M Kassiou Expert Opinion on Drug Discovery 18 (6), 597-613, 2023 | 8 | 2023 |
| The discovery of a potent and selective pyrazolo-[2, 3-e]-[1, 2, 4]-triazine cannabinoid type 2 receptor agonist M Moir, S Lane, AP Montgomery, D Hibbs, M Connor, M Kassiou European Journal of Medicinal Chemistry 210, 113087, 2021 | 5 | 2021 |
| Synthesis and evaluation of various heteroaromatic benzamides as analogues of–ylidene-benzamide cannabinoid type 2 receptor agonists M Moir, R Boyd, H Gunosewoyo, AP Montgomery, M Connor, M Kassiou Tetrahedron letters 60 (36), 151019, 2019 | 5 | 2019 |
| Strategies for targeting the P2Y12 receptor in the central nervous system BB Ma, AP Montgomery, B Chen, M Kassiou, JJ Danon Bioorganic & Medicinal Chemistry Letters 71, 128837, 2022 | 4 | 2022 |
| Sialyltransferase Inhibitors as Potential Anti-Cancer Agents D Skropeta, C Dobie, AP Montgomery, H Steele, R Szabo, H Yu Australian Journal of Chemistry 74 (11), 758-766, 2021 | 4 | 2021 |
| Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism R Sokias, EL Werry, HWA Cheng, JH Lloyd, G Sohler, JJ Danon, ... European Journal of Medicinal Chemistry 207, 112725, 2020 | 4 | 2020 |
| Synthesis and biological evaluation of selective phosphonate-bearing 1, 2, 3-triazole-linked sialyltransferase inhibitors C Dobie, AP Montgomery, R Szabo, H Yu, D Skropeta RSC Medicinal Chemistry 12 (10), 1680-1689, 2021 | 3 | 2021 |
| Synthesis and Preclinical Evaluation of Fluorinated 5-Azaindoles as CB2 PET Radioligands A Kallinen, K Mardon, S Lane, AP Montgomery, R Bhalla, DHR Stimson, ... ACS Chemical Neuroscience 14 (16), 2902-2921, 2023 | 2 | 2023 |
| Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies HWA Cheng, TB Callis, AP Montgomery, JJ Danon, WT Jorgensen, YD Ke, ... International Journal of Molecular Sciences 23 (23), 14769, 2022 | 2 | 2022 |
| Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia SL Carey-Smith, MH Simad, K Panchal, C Aya-Bonilla, H Smolders, S Lin, ... Haematologica, 2020 | 1 | 2020 |
| Rational Design of Inhibitors Targeting Human Sialyltransferases AP Montgomery | | 2019 |
| Fragment-Based Drug Discovery for Disorders of the Central Nervous System: Designing Better Drugs Piece by Piece BWGL Chan, NB Lynch, W Tran, JM Joyce, AP Montgomery, GP Savage, ... Frontiers in Chemistry 12, 1379518, 0 | | |
